M Ventures is the strategic corporate venture capital arm of Merck KGaA, Darmstadt, Germany, investing in Biotechnology and Technology. It invests globally in transformational ideas across healthcare, life science, and electronics from its headquarters in Amsterdam.
34% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (12 deals in the last 12 months vs 19 prior). Average disclosed round size is $36.7M (across 137 rounds with reported amounts).
Portfolio
138
Fund Size
$677M
Top Stage
Series A
Last 12 Mo
12
Team
Vijay Narasimhan
Director of Technology Investments and Partnerships
Emma Johnson
Senior Principal
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
194 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Remepy | Series A | $36M | Aug 2026 |
 Cyllene | Series C | — | Jul 2026 |
 Gency AI | Series B | $20M | Mar 2026 |
 Theolytics | Unknown | — | Mar 2026 |
 Consio AI | Seed | $3.3M | Jan 2026 |
| CConsio | Seed | $3.3M | Jan 2026 |
 Vizgen | Series C | $48M | Jan 2026 |
 Lightcast | Unknown | $27M | Jan 2026 |
 FoRx Therapeutics | Series A | $50M | Dec 2025 |
 NovoLINC | Unknown | — | Dec 2025 |
 Artios | Series D | $115M | Nov 2025 |
 FMC | Series C | — | Nov 2025 |
 NRG Therapeutics | Series B | $50M | Sep 2025 |
 Actithera | Series A | $75.5M | Jul 2025 |
 ReproNovo | Series A | $65M | May 2025 |
 Stimuler | Seed | $3.8M | Apr 2025 |
 Forge Nano | Unknown | $40M | Apr 2025 |
 ChEmpower | Series A | $18.7M | Apr 2025 |
 Corvic | Seed | $12M | Apr 2025 |
| CCorvic AI | Seed | $12M | Apr 2025 |
 MemryX | Series B | $44M | Mar 2025 |
 TRIMTECH Therapeutics | Seed | $14M | Mar 2025 |
| HHD | Unknown | $7.8M | Feb 2025 |
| NovoLINC | Seed | — | Jan 2025 |
 SEEQC | Series A | — | Jan 2025 |
Page 1 of 8
Top Co-Investors
Sofinnova Partners22 shared
Pfizer Ventures22 shared
Merck19 shared
SV Health Investors14 shared
Andera Partners12 shared
Novartis Venture Fund11 shared
IP Group plc11 shared
INKEF Capital10 shared
EQT Life Sciences9 shared
Omega Funds9 shared
Illumina Ventures8 shared
RA Capital Management8 shared
Schroders Capital8 shared
Arix Bioscience7 shared
Novartis Pharma AG7 shared
Foothill Ventures7 shared
ARCH Venture Partners7 shared
Alexandria Venture Investments6 shared
AbbVie6 shared
Avidity Partners6 shared
Last updated: 7 October 2026